EXHALIX, LLC
Localized hydrogen sulfide donor therapy for diabetic foot ulcer healing
- Sector
- Biotech
- Headquarters
- Albuquerque, NM
- Total capital
- $6.4M
- Federal grants
- $6.4M
- 11 awards · 2016–2025
- Rank in peer group#105 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 5 pending · first 2020
- Rank in peer group#142 of 514
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Genie:S: On-Demand Sulfide Synthesis and Delivery Platform Technology for Ischemia Therapy$350K
- Federal grantHealth and Human S · Phase I · A Hydrogen Sulfide Delivery Technology for Organ Preservation Therapy$248K
- Federal grantHealth and Human S · Phase II · HEALS™: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing$716K
- Federal grantHealth and Human S · Phase II · HEALS™: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing$1.2M
- Federal grantHealth and Human S · Phase I · Repair by Local Infusion of Sulfides (ReLIS™) for Treatment of Disadvantaged Surgical Incisions$300K
- Federal grantHealth and Human S · Phase II · Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease$500K
- Federal grantHealth and Human S · Phase I · HEALS™: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing$300K
Show 4 earlier federal awards
- Federal grantHealth and Human S · Phase I · Dynamic Breath Gas Sensor (DBGS™) for Detection of Pulmonary Edema$298K
- Federal grantHealth and Human S · Phase II · Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease$709K
- Federal grantHealth and Human S · Phase II · Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease$1.5M
- Federal grantNSF · Phase I · SBIR Phase I: Noninvasive Sensor for Remote Monitoring of Peripheral Artery Disease$270K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#105 · top 20%
- Granted patents#142 · top 28%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 7- PendingHydrogen Sulfide Delivery DeviceUSPTOApplication 19123464
- PendingTransdermal Sampling Strip And Method For Analyzing Transdermally Emitted GasesUSPTOApplication 18794369
- GrantedTransdermal Sampling Strip And Method For Analyzing Transdermally Emitted GasesUSPTOUS 12,053,281
Show all 7 patent records
- Hydrogen Sulfide Delivery DeviceJun 4, 2026 · Application 19123464Pending
- Transdermal Sampling Strip And Method For Analyzing Transdermally Emitted GasesNov 28, 2024 · Application 18794369Pending
- Transdermal Sampling Strip And Method For Analyzing Transdermally Emitted GasesAug 6, 2024 · US 12,053,281Granted
- Transdermal Sampling Strip And Method For Analyzing Transdermally Emitted GasesDec 8, 2020 · US 10,856,790Granted
- Hydrogen Sulfide Delivery DeviceApplication 63420454Pending
- Hydrogen Sulfide Delivery DeviceApplication PCTUS2023077974Pending
- Transdermal Sampling Strip And Method For Analyzing Transdermally Emitted GasesApplication PCTUS2016012577Pending
Related companies, and why
- CelLink CorpSimilar federal contract value in Biotech · null in contracts
- PROGENITOR INC.Similar federal contract value in Biotech · null in contracts
- CELLECHO INCSimilar federal contract value in Biotech · null in contracts
- Stem Cell Theranostics, Inc.Similar federal contract value in Biotech · null in contracts
- BIOTECERA INC.Similar federal contract value in Biotech · null in contracts
- DRIVE THERAPEUTICS, L.L.C.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .